The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation-Reference-Cited by-同舟云学术

The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation

Published:2019-07-03 Issue:9 Volume:41 Page:3362-3371
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Kim Song Hee¹,Lee Won Hyeok¹,Seong Daseul¹,An Jae Hee¹,Je Hyoung Uk²,Nam Hae Yun³,Kim Sang Yoon⁴,Kim Seong Who³,Han Myung Woul¹⁵^ORCID

Affiliation:

1. Department of OtolaryngologyUlsan University Hospital, University of Ulsan College of Medicine Ulsan Republic of Korea

2. Department of Radiation OncologyUlsan University Hospital, University of Ulsan College of Medicine Ulsan Republic of Korea

3. Department of Biochemistry and Molecular BiologyAsan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea

4. Department of OtolaryngologyAsan Medical Center, University of Ulsan College of Medicine Seoul Republic of Korea

5. Department of Otolaryngology‐Head and Neck SurgeryLondon Health Sciences Center, Schulich School of Medicine & Dentistry, Western University London Ontario Canada

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25868

Reference37 articles.

1. TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

2. TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck

3. TP53Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response

4. Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target

5. CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons;Diagnostics;2022-12-05

2. Integrative assessment of CIP2A overexpression and mutational effects in human malignancies identifies possible deleterious variants;Computers in Biology and Medicine;2021-12

3. Relationship between p53 status and the bioeffect of ionizing radiation (Review);Oncology Letters;2021-07-14

4. Cip2A modulates osteogenic differentiation via the ERK‐Runx2 pathway in MG63 cells;BioFactors;2021-06-02

5. Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma;Journal of Cancer Prevention;2020-03-30